JPRN-UMIN000004492已完成未知
Clinical trial aimed at new therapeutic approch against HAM patients by pentosan polysulphate - Clinical trial against HAM patients by pentosan polysulphate
Department of Molecular Microbilogy and Immunology0 个研究点目标入组 15 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients who both prothrombin time and activated partial thromboplastin time are more than normal ranges at screening test
研究者
相似试验
已完成
不适用
Clinical trial aimed at new therapeutic strategy for HAM by prosultiamine treatment with oral administratioHTLV-I associated myelopathy (HAM)JPRN-UMIN000005969The Department of Molecular Microbiology and Immunology25
进行中（未招募）
2 期
Study on efficacy of herbal drugs in reducing viral load in HIV/AIDS patientsCTRI/2022/09/045548MVR Ayurveda medical college
招募中
3 期
Thalidomide effects in COVID-19Covid 19.Covid 19IRCT20110423006257N3Arak University of Medical Sciences66
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisactinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKactinic keratosisEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15